Although sleep disorders are often difficult to treat, increased knowledge regarding the disordered sleep associated with ASD could lead to effective treatments for these patients.
This study was done by the Autism and Developmental Disabilities Monitoring Network. In this observational program, prevalence of autism spectrum disorder is estimated and the timing of ASD identification among children aged 4 and 8 years is monitored.
Researchers conducted a 24-week phase 2 trial of intranasal oxytocin therapy in pediatric patients with autism spectrum disorder to divulge whether it would improve social functioning.
Researchers determined the efficacy of a preemptive intervention at reducing the severity of autism symptoms and the likelihood of an autism spectrum disorder (ASD) diagnosis in infants showing early signs of ASD.
Researchers assessed the association between maternal use of epidural analgesia during labor and delivery with the risk of developing autism in offspring.
For children with ASD, the administration of intranasal oxytocin therapy during a 24-week period does not significantly improve the score for a measure of social interaction.
